Daré Bioscience, Inc. DARE

I $DARE you to buy this?

Showed up on finviz scan today! Good news yesterday, now all we need is volume

$DARE $MARK volume, volume, volume......bullllllls!

Pretty sure this ticker caught the corona virus.

Make than 70 cents

I’ll buy more at 75 cents if it ever gets there.

Dare Dare Dare...when you gonna find whatever it is you are lookin for?

DARE-BV1
Bacterial vaginosis (BV) is the most common type of vaginal infection in women of reproductive age. In the U.S. alone, an estimated 21 million women aged 14-49 years have BV. Current treatment often consists of oral antibiotics, but research has shown effective drug delivery is essential to optimizing drug therapy for BV.

DARE-BV1 is a thermosetting vaginal gel formulated with clindamycin phosphate 2% designed for prolonged, localized release of the antibiotic. In an investigator-initiated proof-of-principal study, an 86% clinical cure rate after one dose of DARE-BV1 was demonstrated (n=28).

A single Phase 3 clinical trial of DARE-BV1, if successful, is expected to support US FDA marketing approval.

Can’t wait to get out of this stock.

But common mostly all stocks today red